학술논문
Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study
Document Type
Article
Author
Pires da Silva, I.; Ahmed, T.; Carlino, M.S.; Lo, S.N.; Menzies, A.M.; Long, G.V.; Nguyen, K.; Reijers, I.L.M.; Blank, C.U.; Weppler, A.M.; Sandhu, S.; Betof Warner, A.; Patrinely, J.R.; Johnson, D.B.; Serra-Bellver, P.; Lorigan, P.; Allayous, C.; Lebbe, C.; Mangana, J.; Zimmer, L.; Trojaniello, C.; Ascierto, P.A.; Stout, D.; Haydon, A.; Lyle, M.; Klein, O.; Gerard, C.L.; Michielin, O.
Source
In: The Lancet Oncology . (The Lancet Oncology, June 2021, 22(6):836-847)
Subject
Language
English
ISSN
14745488
14702045
14702045